Vaccine Adjuvants Market : Future of biotechnology , it is Creating Real Change in the biotechnology Industry

The global vaccine adjuvants market is expected to reach USD 769.4 Million by 2021 from USD 467.0 Million in 2016, at a CAGR of 10.5%. The global market is broadly classified into product type, route of administration, disease type, applications, and application categories.

The global market is broadly classified into product type, route of administration, disease type, applications, and application categories.
On the basis of product type, the market is segmented into pathogen components, adjuvant emulsions, particulate adjuvants, combination adjuvants, and other adjuvants.

Access Free Sample Research Copy : https://www.marketsandmarkets.com/requestsampleNew.asp?id=152603894

                         
Global Vaccine Adjuvants Market Segmentation:

The global market is broadly classified into product type, route of administration, disease type, applications, and application categories.

+ On the basis of product type, the vaccine adjuvants market is segmented into pathogen components, adjuvant emulsions, particulate adjuvants, combination adjuvants, and others. The particulate adjuvants segment is expected to account for the largest share of the global market in 2016. The adjuvant emulsions segment, on the other hand, is projected to grow at the highest CAGR during the forecast period.

+ On the basis of route of administration, the market is segmented into oral, subcutaneous, intranasal, intramuscular, intradermal, and others. The intramuscular segment is expected to account for the largest share of the global vaccine adjuvants market in 2016.

+ On the basis of disease type, the vaccine adjuvants market is segmented into infectious diseases, cancer, and others. The infectious diseases segment is expected to account for the largest share of the global market in 2016. Factors such as high prevalence of infectious diseases, government & company initiatives, and high prevalence of cancer cases are expected to drive market growth in the coming years.

Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=152603894

What Drives the Market?

1. Increasing Use of Adjuvants in Vaccine
2. High Prevalence of Infectious and Zoonotic Diseases
3. Increase in Livestock and Instances of Diseases
4. Increasing Focus on Immunization Programs From Various Government Bodies
5. Technological Advancements in Aluminum Hydroxide-Based Adjuvants
6. Increasing Focus and Support on the Discovery and Development of Vaccine Adjuvants
7. Increasing Geriatric Population

Get Expert Analysis and Insights of Global Market | Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=152603894

Geographical Growth Analysis:

Geographically, the vaccine adjuvants market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). However, Asia is projected to grow at the highest CAGR during the forecast period. Growth in the North American segment is primarily driven by the increasing geriatric population and rising incidences of diseases in the North American countries.

Synthetic Biology Market - Opening New Avenues for Growth in the market

The synthetic biology market comprises a network of players involved in the research and product development; raw material supply; component manufacturing; distribution and sale; and post-sales services. Key players considered in the analysis of the global market are Thermo Fisher (US), Novozymes (Denmark), Merck KGaA (Germany), Intrexon (US), and Agilent Technologies (US), Amyris (US), GenScript (US), Ginkgo Bioworks (US), Integrated DNA Technologies (US), New England Biolabs (US), Synthetic Genomics (US), and Twist Bioscience (US).

The global synthetic biology market is expected to grow from USD 3.57 billion in 2017 to USD 8.84 billion by 2022, at a CAGR of 19.9% from 2017 to 2022.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=889

                          
Synthetic biology has an array of applications in the fields of medicine, agriculture, nanotechnology, and industrial biotechnology. This has attracted interests of researchers from across the globe and has led to a rise in funding from public and private organizations, which, in turn, help in the growth of the market.

Additionally, the reduction in costs per raw megabase of DNA sequencing and a drastic reduction in the cost of synthetic genes is expected to propel the market growth of synthetic biology. The base year considered for the study is 2016, and the forecast has been provided for the period between 2017 and 2022.

Global Synthetic Biology Market Segmentation:

In this report, the market is segmented by tool, technology, application, and region. On the basis tool, the synthetic biology market is segmented into oligonucleotides, enzymes, cloning technology kits, chassis organisms, and xeno-nucleic acids. The chassis organisms segment is expected to grow at the highest rate during the forecast period. The increasing demand for green alternatives (biomass is converted to chemicals using engineered bacteria, yeasts, and other microorganisms) to fossil fuels is a key driver for this segment.

By technology, the market is segmented into gene synthesis, genome engineering, cloning and sequencing, next-generation sequencing, site-directed mutagenesis, measurement and modeling, microfluidics, and nanotechnology. In 2017, the gene synthesis segment is expected to account for the largest share of the market in technology.

The market is segmented into medical (pharmaceutical, drug discovery & therapeutics, and artificial tissue and tissue regeneration), industrial (biofuel & renewable energy, industrial enzymes, and biomaterials & green chemicals), food & agriculture, and environmental (bioremediation and biosensing) on the basis of application.

Get Expert Analysis and Insights of Global Market | Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=889

Wide range of applications of synthetic biology drives the global synthetic biology market

The field of medicine has been in the forefront in terms of developing and applying synthetic biology techniques for various applications. Advancements in DNA sequencing and synthesizing technologies have resulted in the better understanding of diseases, aiding the research and discovery of biopharmaceuticals, small molecules, regenerative medicine, and antibody research.

Additionally, synthetic biology has major applications in developing disease-resistant, drought-tolerant, and high-yielding crop. Similarly, industrial applications of synthetic biology are expected to replace petrochemicals with bio-based chemicals in the near future. The growing applications of synthetic biology is a major driver for the growth of this market.

Non Invasive Prenatal Testing (NIPT) to Expand at a Healthy Growth Rate in the Coming Years

The major factors driving the growth of this market include the growing preference for non-invasive techniques over invasive methods, rising focus on reimbursement for NIPT, the launch of new and advanced NIPT products, and increasing maternal age (growth in the risk of chromosomal abnormalities in babies).

Please share your specific interest to serve you better, Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=145607690

What the Market Looks Like?

Predicted to grow at a CAGR of 13.5% during the forecast period,the global non-invasive prenatal testing (NIPT) market is estimated to reach USD 7.3 billion by 2024 from USD 3.9 billion in 2019. The global Non Invasive Prenatal Testing (NIPT)Growth in this market is driven by the high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, improving reimbursement scenario for NIPT, and increasing awareness of NIPT. However, a dearth of skilled professionals is restraining the growth of this market.

> By method, the NIPT products market is segmented into ultrasound detection, biochemical screening tests, and cell-free DNA in maternal plasma tests. The cfDNA in maternal plasma tests segment is expected to grow at the highest CAGR during the forecast period.

> Based on application, the non-invasive prenatal testing (NIPT) market is segmented into trisomy, microdeletion syndrome, and other applications (gender identification and the detection of monogenic disorders, Klinefelter syndrome, and Rhesus (Rh) blood type).

> Based on end user, the NIPT products market is classified into diagnostic laboratories and hospitals. In 2019, diagnostic laboratories formed the largest and fastest-growing end users of NIPT products.

Get Sample Copy of This Report
@https://www.marketsandmarkets.com/requestsampleNew.asp?id=145607690

What Drives the Market?

The growth of the global market for Non Invasive Prenatal Testing (NIPT) is primarily influenced by the following factors:

• High Risk of Chromosomal Abnormalities With Increasing Maternal Age
• Growing Preference for Noninvasive Techniques Over Invasive Methods
• Improving Reimbursement Scenario for NIPT
• Programs Focusing on Increasing the Awareness of NIPT

Untapped emerging markets are expected to offer potential growth opportunities to players operating in the NIPT market during the forecast period. On the other hand, a dearth of skilled professionals is expected to restrain the growth of this market in the coming years.

Geographical growth scenario of Non Invasive Prenatal Testing (NIPT) :

Geographically, Non Invasive Prenatal Testing (NIPT) market has been studied for North America dominated the market, followed by Europe. The large share of this market can primarily be attributed to the strong economies in the US and Canada, which have allowed for significant investments in technology in this region.

Leading market players and strategies adopted

The NIPT market is diversified and highly competitive, with a large number of players competing for market space. The prominent players in the market are Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), GE Healthcare (US), BGI (China), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), PerkinElmer Inc. (US), Laboratory Corporation of America Holdings (US), Natera, Inc. (US), and Yourgene Health (UK)

Read More: https://www.marketsandmarkets.com/PressReleases/non-invasive-prenatal-testing.asp